Vertex to Acquire Crinetics for $10 Billion in Major Rare Disease Expansion
The deal adds PALSONIFY (paltusotine) and late-stage CAH therapy to Vertex’s portfolio.
/ 220 items
#andre↓
Vista Equity and Quinti Capital Bid for Criteo in Deal Valued at 50% Premium
French commerce media company Criteo gets takeover proposal from Vista Equity and Quinti Capital at over 50% premium to current share price.
Broadcom and Apple Extend Partnership Through 2031 with Multi-Year Custom Chip Deal
The new multi-year agreement covers custom ASIC silicon and wireless components.
TeraWulf Secures $19 Billion, 20-Year Deal with Anthropic for 401 MW AI Data Center
TeraWulf secures a 20-year lease with Anthropic for a 401 MW AI data center in Kentucky, projecting $19B in revenue. Also divests 50.1% stake in Texas project at a profit.
Ceva Secures Major AI Licensing Deal with U.S. Tech Giant for NeuPro-M
A leading U.S. AI platform company has chosen Ceva’s NeuPro-M for custom AI chips in next-gen smart devices.
Novartis to Acquire Myricx Bio for Up to $1.5 Billion to Bolster Next-Gen ADC Pipeline
Novartis is gaining B7-H3 and HER2 ADCs with innovative NMTi technology designed to overcome cancer resistance.